Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update

Autonomix Medical, Inc. (NASDAQ:AMIXGet Free Report) was the recipient of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 75,900 shares, a decrease of 23.9% from the February 13th total of 99,700 shares. Based on an average daily volume of 347,600 shares, the short-interest ratio is presently 0.2 days. Currently, 4.4% of the company’s stock are sold short.

Institutional Trading of Autonomix Medical

A hedge fund recently bought a new stake in Autonomix Medical stock. Citadel Advisors LLC purchased a new position in Autonomix Medical, Inc. (NASDAQ:AMIXFree Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 47,884 shares of the company’s stock, valued at approximately $180,000. Citadel Advisors LLC owned approximately 4.16% of Autonomix Medical as of its most recent filing with the Securities and Exchange Commission (SEC). 10.78% of the stock is currently owned by hedge funds and other institutional investors.

Autonomix Medical Stock Performance

Shares of Autonomix Medical stock opened at $1.90 on Wednesday. The firm has a fifty day moving average of $2.73 and a two-hundred day moving average of $7.09. Autonomix Medical has a one year low of $1.83 and a one year high of $75.80. The company has a market cap of $4.68 million, a P/E ratio of -0.15 and a beta of -5.40.

Autonomix Medical (NASDAQ:AMIXGet Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported ($1.46) earnings per share (EPS) for the quarter. As a group, equities analysts predict that Autonomix Medical will post -10 earnings per share for the current year.

About Autonomix Medical

(Get Free Report)

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.

Featured Articles

Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.